Email campaigns that sound like your team wrote every word.
Subject lines, preview text, email body, and PS line — all generated from one brief, all in the voice your audience already recognizes. Ready for review in under a minute.
It's been a while since your last brief run. That usually means one of two things: either you shipped everything and moved on (nice), or the campaign planning got busy and copy became the thing that waits…
Email copy review cycles compound the launch delay
Most email programs have a consistent cadence — weekly newsletters, campaign launches, drip sequences — but the copy bottleneck resets with every send. A brief goes to a writer, the writer produces a draft, the draft goes to a reviewer, the reviewer sends notes, the writer revises, the notes go back. Three rounds is average. Five happens more than anyone admits.
The harder problem: most revision rounds are about voice, not content. The ideas are correct. The email just doesn't sound like the company. Quillpilot doesn't fix your email strategy — that judgment stays with your team. What it removes is the revision loop that's really just a brand voice alignment problem.
The brief drives the email. The voice profile drives the copy.
Enter your campaign goal, audience segment, key message, and tone. Quillpilot's email Channel Adapter generates a subject line (in your preferred formula), preview text, email body, and optional PS line — all referencing your brand voice profile, so revision notes are about content, not style.
- Subject line formula matched to your brand (benefit-led, curiosity, question)
- Body tone matches voice profile — formal, conversational, or mixed
- Integrated with major email platforms via direct export
- Approval flow keeps sign-off in the tool, not in the inbox
"We send a weekly newsletter and a launch email most weeks. Quillpilot halved my copy time. The subject line test is the part I actually look forward to now."
Your next email campaign is 20 minutes away.
Start free — no credit card. Full platform access on trial.